Application of the Carolina Framework for Cervical Cancer Prevention
- PMID: 24333357
- PMCID: PMC4020939
- DOI: 10.1016/j.ygyno.2013.12.004
Application of the Carolina Framework for Cervical Cancer Prevention
Abstract
Objective: The Carolina Framework for Cervical Cancer Prevention describes 4 main causes of cervical cancer incidence: human papillomavirus (HPV) infection, lack of screening, screening errors, and not receiving follow-up care. We present 2 applications of the Carolina Framework in which we identify high-need counties in North Carolina and generate recommendations for improving prevention efforts.
Methods: We created a cervical cancer prevention need index (CCPNI) that ranked counties on cervical cancer mortality, HPV vaccine initiation and completion, Pap smear screening, and provision of Pap tests to rarely- or never-screened women. In addition, we conducted in-depth interviews with 19 key informants from programs and agencies involved in cervical cancer prevention in North Carolina.
Results: North Carolina's 100 counties varied widely on individual CCPNI components, including annual cervical cancer mortality (median 2.7/100,000 women; range 0.0-8.0), adolescent girls' HPV vaccine initiation (median 42%; range 15%-62%), and Pap testing in the previous 3 years among Medicaid-insured adult women (median 59%; range 40%-83%). Counties with the greatest prevention needs formed 2 distinct clusters in the northeast and south-central regions of the state. Interviews generated 9 recommendations to improve cervical cancer prevention in North Carolina, identifying applications to specific programs and policies in the state.
Conclusions: This study found striking geographic disparities in cervical cancer prevention need in North Carolina. Future prevention efforts in the state should prioritize high-need regions as well as recommended strategies and applications in existing programs. Other states can use the Carolina Framework to increase the impact of their cervical cancer prevention efforts.
Keywords: Cancer prevention; Cervical cancer; Health disparities; Human papillomavirus (HPV) vaccine; Pap test.
Copyright © 2013 Elsevier Inc. All rights reserved.
Conflict of interest statement
NB has received grants or served on paid advisory boards for GlaxoSmithKline and Merck Sharp & Dohme Corp.
Figures
Similar articles
-
Primary Care Physicians' Adherence to Expert Recommendations for Cervical Cancer Screening and Prevention in the Context of Human Papillomavirus Vaccination.Sex Transm Dis. 2016 Jul;43(7):438-44. doi: 10.1097/OLQ.0000000000000458. Sex Transm Dis. 2016. PMID: 27322046 Free PMC article.
-
Economic evaluation of policy options for prevention and control of cervical cancer in Thailand.Pharmacoeconomics. 2011 Sep;29(9):781-806. doi: 10.2165/11586560-000000000-00000. Pharmacoeconomics. 2011. PMID: 21838332
-
Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.J Womens Health (Larchmt). 2017 Oct;26(10):1114-1122. doi: 10.1089/jwh.2017.6424. Epub 2017 Aug 25. J Womens Health (Larchmt). 2017. PMID: 28841084 Free PMC article.
-
Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.Vaccine. 2013 Dec 29;31 Suppl 5:F47-52. doi: 10.1016/j.vaccine.2012.06.066. Vaccine. 2013. PMID: 24331747 Review.
-
Global strategies for cervical cancer prevention.Curr Opin Obstet Gynecol. 2016 Feb;28(1):4-10. doi: 10.1097/GCO.0000000000000241. Curr Opin Obstet Gynecol. 2016. PMID: 26642063 Review.
Cited by
-
County-level characteristics associated with incidence, late-stage incidence, and mortality from screenable cancers.Cancer Epidemiol. 2021 Dec;75:102033. doi: 10.1016/j.canep.2021.102033. Epub 2021 Sep 21. Cancer Epidemiol. 2021. PMID: 34560364 Free PMC article.
-
Knowledge of cervical cancer, human papillomavirus and prevention among first-year female students in residences at the University of the Free State.Afr J Prim Health Care Fam Med. 2018 May 24;10(1):e1-e5. doi: 10.4102/phcfm.v10i1.1637. Afr J Prim Health Care Fam Med. 2018. PMID: 29943594 Free PMC article.
-
Exploratory Analysis of Concordance Between Clinician-Collected and Self-Sampled Human Papillomavirus Tests in a Small Cohort of Average- and High-Risk Patients.Womens Health Rep (New Rochelle). 2024 Mar 13;5(1):259-266. doi: 10.1089/whr.2024.0004. eCollection 2024. Womens Health Rep (New Rochelle). 2024. PMID: 38516651 Free PMC article.
-
Impact of Pharmacists on Access to Vaccine Providers: A Geospatial Analysis.Milbank Q. 2018 Sep;96(3):568-592. doi: 10.1111/1468-0009.12342. Milbank Q. 2018. PMID: 30203603 Free PMC article.
-
Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.J Womens Health (Larchmt). 2019 Aug;28(8):1094-1104. doi: 10.1089/jwh.2018.7141. Epub 2019 Mar 15. J Womens Health (Larchmt). 2019. PMID: 30874477 Free PMC article.
References
-
- Grauman DJ, Tarone RE, Devesa SS, Fraumeni JF., Jr Alternate ranging methods for cancer mortality maps. J Natl Cancer Inst. 2000;92(7):534–543. - PubMed
-
- Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER cancer statistics review, 1975–2008. 2011
-
- U.S. Preventive Services Task Force. Screening for cervical cancer, topic page. [Accessed November 7, 2013.];Updated 2012.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials